Citalopram Hydrobromide
- Product NDC
- 68071-1830
- 11-digit product format
- 680711830
- Labeler code
- 68071
- Product ID
- 68071-1830_2a9687f5-a055-ea3f-e063-6294a90a9db3
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Citalopram Hydrobromide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- NuCare Pharmaceuticals,Inc.
- Application
- ANDA078216
- Marketing category
- ANDA
- Marketing start
- 2007-10-18
- Substance
- CITALOPRAM HYDROBROMIDE
- Active strength
- 20 mg/1
- Pharmacologic classes
- Serotonin Reuptake Inhibitor [EPC], Serotonin Uptake Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Citalopram Hydrobromide
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| CITALOPRAM HYDROBROMIDE | 20 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | I1E9D14F36 |
| Rxcui | 200371 |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 68071-1830-1 | Citalopram Hydrobromide | 100 in 1 BOTTLE | TABLET | 100 | | 2 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 68071-1830 | CITALOPRAM HYDROBROMIDE TABLET [NUCARE PHARMACEUTICALS,INC.] | 2 | Current NDC, Legacy NDC, 1 package rows | 20250101_c584909b-e7b2-7108-e053-2995a90a2f54.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 68071-1830-1 | 68071183001 | 100 TABLET in 1 BOTTLE (68071-1830-1) | 100 tablet | 2021-06-24 | 0000-00-00 | No | No | Current |